Wave Life Sciences Files 2024 Annual Report Amendment
Ticker: WVE · Form: 10-K/A · Filed: Apr 29, 2025 · CIK: 1631574
| Field | Detail |
|---|---|
| Company | Wave Life Sciences Ltd. (WVE) |
| Form Type | 10-K/A |
| Filed Date | Apr 29, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceuticals
TL;DR
Wave Life Sciences amended its 2024 10-K, check for updates.
AI Summary
Wave Life Sciences Ltd. filed an amendment (10-K/A) on April 29, 2025, for its fiscal year ending December 31, 2024. The company, incorporated in Singapore, is involved in the pharmaceutical preparations industry. Its business address is in Singapore, while its mailing address is in Cambridge, MA.
Why It Matters
This filing provides updated information for the fiscal year 2024, which is crucial for investors to assess the company's performance and strategic direction.
Risk Assessment
Risk Level: low — This is a routine amendment to an annual report, not indicating new or elevated risks.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the amended annual report.)
- 2025-04-29 — Filing Date (The date the amendment was submitted to the SEC.)
Key Players & Entities
- Wave Life Sciences Ltd. (company) — Registrant
- 2024-12-31 (date) — Fiscal year end
- 2025-04-29 (date) — Filing date
- Singapore (location) — Jurisdiction of incorporation
- Cambridge, MA (location) — Mailing address
FAQ
What is the primary purpose of this 10-K/A filing?
This 10-K/A filing serves as an amendment to the annual report for the fiscal year ended December 31, 2024, providing updated information.
When was this amendment filed with the SEC?
The amendment was filed on April 29, 2025.
What is Wave Life Sciences Ltd.'s fiscal year end?
Wave Life Sciences Ltd.'s fiscal year ends on December 31.
Where is Wave Life Sciences Ltd. incorporated?
Wave Life Sciences Ltd. is incorporated in Singapore.
What is the SIC code for Wave Life Sciences Ltd.?
The Standard Industrial Classification (SIC) code for Wave Life Sciences Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 29, 2025 regarding Wave Life Sciences Ltd. (WVE).